Literature DB >> 16549413

Selective reduction of amyloid beta42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation.

B Mollenhauer, M Bibl, H Esselmann, P Steinacker, C Trenkwalder, P Brechlin, J Wiltfang, M Otto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16549413      PMCID： PMC2077534          DOI： 10.1136/jnnp.2005.084673

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

Review 1.  From Alzheimer to Huntington: why is a structural understanding so difficult?

Authors:  Piero Andrea Temussi; Laura Masino; Annalisa Pastore
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

2.  Alzheimer-type lesions in Huntington's disease.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

3.  Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.

Authors:  Mirko Bibl; Hermann Esselmann; Markus Otto; Piotr Lewczuk; Lukas Cepek; Eckart Rüther; Johannes Kornhuber; Jens Wiltfang
Journal:  Electrophoresis       Date:  2004-09       Impact factor: 3.535

4.  Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Authors:  Jens Wiltfang; Hermann Esselmann; Alexander Smirnov; Mirko Bibl; Lukas Cepek; Petra Steinacker; Brit Mollenhauer; Katharina Buerger; Harald Hampel; Sabine Paul; Manuela Neumann; Manuel Maler; Inga Zerr; Johannes Kornhuber; Hans A Kretzschmar; Sigrid Poser; Markus Otto
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

Review 5.  Huntington's disease.

Authors:  Marcy E MacDonald; Silvia Gines; James F Gusella; Vanessa C Wheeler
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.